Ingunn Munch Lindvig

SVP, Regulatory Affairs at BioInvent International

Ingunn Munch Lindvig currently serves as the Senior Vice President of Regulatory Affairs at BioInvent International AB since June 2023. Prior to this role, Ingunn held the position of Vice President and Head of Regulatory Affairs at Circio Holding ASA from July 2019 to June 2023, and led Regulatory Affairs at Nordic Nanovector ASA from October 2014 to June 2019. Earlier experience includes serving as Global Director of Regulatory Affairs at Photocure ASA from October 2007 to September 2014, and as a Senior Regulatory Advisor and Regulatory Advisor at GE Healthcare between October 1996 and December 2007. Ingunn earned a PhD in Biology: Physiology from the University of Oslo, where studies were completed from 1985 to 1996.

Location

Innlandet, Norway

Links


Org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


BioInvent International

BioInvent International AB (Nasdaq Stockholm: BINV) is a clinical-stage biotech company that discovers and develops novel and first-in-class immuno-modulatory antibodies for cancer therapy, with currently three drug candidates in four ongoing clinical programs in Phase l/ll trials for the treatment of hematological cancer and solid tumors, respectively.


Industries

Headquarters

Lund, Sweden

Employees

51-200

Links